Published in Br Med J on February 13, 1971
Tissue- and species-specific antigens of normal human prostatic tissue. J Immunol (1970) 1.22
Acid phosphatase content of prostatic exprimate from patients with advanced prostatic carcinoma: a potential prognostic and therapeutic index. Cancer (1970) 0.97
HISTOCHEMISTRY OF THE NORMAL, HYPERPLASTIC, AND NEOPLASTIC HUMAN PROSTATE GLAND. Invest Urol (1964) 0.95
Aetiology of Kaposi's sarcoma. Lancet (1990) 1.95
Tissue- and species-specific antigens of normal human prostatic tissue. J Immunol (1970) 1.22
The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytes. J Immunol (1974) 1.21
Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol (1970) 1.18
Thymus-specific antigens on human thymocytes and on thymic-derived lymphocytes. Transplantation (1973) 1.10
IgE in pemphigus. Arch Dermatol (1977) 1.09
Immunologic studies of normal, benign, and malignant human prostatic tissue. Cancer (1972) 1.09
Precipitating antigens of the normal human prostate. J Reprod Fertil (1970) 1.04
Pemphigus-like antibodies in patients with skin burns. Vox Sang (1969) 1.02
Precipitating antibody in the sera of patients treated cryosurgically for carcinoma of the prostate. Exp Med Surg (1969) 0.98
Serum proteins in patients with benign and malignant diseases of the prostate. Neoplasma (1971) 0.97
Blood product immunosuppression and the acquired immunodeficiency syndrome. Ann Intern Med (1986) 0.97
Alterations of alpha2-globulin and the clinical response in patients with prostatic cancer following cryotherapy. Oncology (1975) 0.91
Localization of immunoglobulins in human prostatic tissue. J Immunol (1971) 0.90
Tissue- and species-specific antibodies in antithymocyte globulin. Transplantation (1972) 0.90
Hormonal therapy and alteration of lymphocyte proliferation. J Lab Clin Med (1976) 0.89
Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate. Cancer Res (1978) 0.89
Condylomata acuminata: treatment by autogenous vaccine. IMJ Ill Med J (1975) 0.87
Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol (1985) 0.87
The female prostate and prostate-specific antigen. Immunohistochemical localization, implications of this prostate marker in women and reasons for using the term "prostate" in the human female. Histol Histopathol (2000) 0.87
Immunochemical characterization of epithelial antigen(s) reactive with pemphigus-like antibodies of rabbit and human pemphigus autoantibodies. J Hyg Epidemiol Microbiol Immunol (1969) 0.87
Cancer, immunological surveillance, and 2 -globulin. Lancet (1972) 0.86
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor. Eur J Cancer (1977) 0.85
Lipofuscin granules in normal, benign and malignant human prostatic tissue. Urol Res (1973) 0.84
Immunopathologic studies of experimental pemphigus-like autoantibodies and bullous-like lesions. J Invest Dermatol (1969) 0.83
Transglutaminase: co-factor in aetiology of AIDS? Lancet (1985) 0.83
A retrospective look at studies on prostate-specific antigen. Clin Chem (1985) 0.82
A tissue type transglutaminase in human seminal plasma. Am J Reprod Immunol (1997) 0.82
Immunosuppression of cell- and serum-medicated tumour-associated immunity in prostatic cancer by human seminal plasma. Eur J Cancer (1980) 0.82
Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res (1986) 0.82
In vivo bound immunoglobulins in the human prostate--their identification and possible significance. Z Immunitatsforsch Exp Klin Immunol (1972) 0.82
Adjuvant immunotherapy (BCG) in stage D prostate cancer. Am J Clin Oncol (1982) 0.82
Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease. Thromb Haemost (1988) 0.81
Letter: Antiepithelial antibodies: a possible clue to malignant neoplasms. Arch Dermatol (1974) 0.81
Fluorescent studies of antibodies to rabbit male urogenital tissue. Experientia (1969) 0.81
Antiepithelial antibodies in the serum of patients with benign and malignant diseases of the prostate. Z Immunitatsforsch Exp Klin Immunol (1973) 0.81
Immunologic sequelae of thermal injury. I. Frequency and relationship of epithelial antibodies to extent of burn. Clin Immunol Immunopathol (1976) 0.81
Cryosurgery of the rabbit prostate. Comparison of the immune response of immature and mature bucks. Cryobiology (1974) 0.81
Autoallergy in pemphigus. Lancet (1968) 0.81
Freezing of the esophagus: histological changes and immunological response. Int Surg (1982) 0.81
Absorption studies on antigen(s) of the esophageal mucosa reactive with autoantibodies of pemphigus. Int Arch Allergy Appl Immunol (1968) 0.80
Carcinoembryonic antigen in the diagnosis of prostate carcinoma. Oncology (1974) 0.80
Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancer. Eur Urol (1980) 0.80
Modulatory effects of estrogen on immunologic responsiveness. III. Effect of hormonal versus nonhormonal therapy on tumor-associated immunity in prostatic cancer. Am J Reprod Immunol (1981) 0.79
Elution of in vivo bound antiprostatic epithelial antibodies following multiple cryotherapy of carcinoma of prostate. Urology (1973) 0.79
Anti-tissue IgG antibodies and deficiency of IgA. Vox Sang (1972) 0.79
Immunotherapy for prostatic cancer. Previous and prospective considerations. Oncology (1975) 0.79
Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration. Urol Int (1976) 0.79
Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancer. Clin Exp Immunol (1979) 0.79
Selective deficiency of IgA. Lancet (1971) 0.79
Androgens and oestrogens may modulate the growth and function of lymphoid organs. J Immunol (1984) 0.79
Tumor-associated immunity in prostatic cancer as evaluated by tube antigen-induced leukocyte adherence inhibition: reactivity and specificity of responsiveness, and relationship to stage, grade and therapy. J Reticuloendothel Soc (1979) 0.78
Immunologic studies of patients with pulmonary emphysema. Ann Allergy (1973) 0.78
Experimental concurrence of pemphigus-like autoantibodies and bullous-like lesions. A preliminary report. Jpn J Med Sci Biol (1969) 0.78
Urinary carcinoembryonic-like antigen levels in patients with bladder carcinoma. J Urol (1974) 0.78
Carcinoembryonic-like antigen in the urine of patients with carcinoma of the bladder and normal controls. J Surg Oncol (1974) 0.78
Cell-mediated immunity in prostatic cancer. Clin Oncol (1980) 0.78
Immunofluorescent identification of a human thymic specific antigen. Blut (1974) 0.78
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of antitumour cell-mediated immunity. Eur J Cancer (1979) 0.78
Cellular immunity in bladder cancer patients. J Urol (1978) 0.78
Immunologic aspects of malignancy. II. Host immunocompetence and relationship to the clinical stage in patients with prostatic cancer. Allergol Immunopathol (Madr) (1976) 0.78
The normal female and the male breast epithelium does not express prostate-specific antigen. Preliminary immunohistochemical observations of autopsy breast tissues. Gen Physiol Biophys (1999) 0.78
Immunosuppressive effect of estrogen on thymic dependent lymphocytic blastogenesis. Urol Res (1974) 0.78
HIV-related protein in the prostate: a possible reservoir of virus. Am J Clin Pathol (1991) 0.78
Immunologic responsiveness & tumour growth of the Dunning R3327 rat prostatic adenocarcinoma following cryosurgery & orchiectomy. Indian J Exp Biol (1982) 0.78
Cytotoxic antibodies to allogenic lymphocytes in prostatic cancer. JAMA (1972) 0.77
A possible immuno-cryothermic response in prostatic cancer. Clin Radiol (1970) 0.77
Hormonal epidemiology of prostatic cancer. Med J Aust (1977) 0.77
Impotence therapy and cancer of the prostate. Am J Surg (1976) 0.77
Cryoimmunotherapy. Br Med J (1972) 0.77
Malignancy associated with antinuclear antibodies. Lancet (1972) 0.77
Immunologic studies of the prostate. A review. Int Surg (1969) 0.77
Sperm-induced urolithiasis in the rat. Eur J Epidemiol (1994) 0.77
Prostate-specific antigen: chronology of its identification. Oncology (Williston Park) (1998) 0.76
Migration-inhibitory effect of serum from patients with prostatic cancer. Oncology (1974) 0.76
Serum immunoglobulin E in pemphigus. J Invest Dermatol (1978) 0.76
Serum antibody in patients with prostatic cancer. Br J Urol (1976) 0.76
On the identification and characterization of prostate-specific antigen. Hum Pathol (1993) 0.76
Cryosurgery of the monkey (macaque) prostate. I. Humoral immunologic responsiveness following cryostimulation. Cryobiology (1976) 0.76
Re: Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer. Br J Urol (1993) 0.76
Biphasic effect of cryosurgery of the prostate on lymphocyte proliferation. Cryobiology (1977) 0.75
Cryosensitivity. Factors influencing development of immunologic response following cyrosurgery of prostate. Urology (1975) 0.75
The identification of prostate-specific antigen. J Clin Lab Anal (1991) 0.75
The female prostate. J Natl Cancer Inst (1998) 0.75
Possible implications of antisperm antibodies beyond infertility. Urology (1991) 0.75
The use of cryosurgery for breast cancer. Arch Surg (1998) 0.75
The identification of prostate-specific antigen. Am J Clin Pathol (1991) 0.75
Treatment of recurrent spontaneous abortion: immunization with seminal plasma trophoblast-lymphocyte crossreacting antigen. Am J Reprod Immunol (1989) 0.75
Pathogenesis of AIDS in hemophilia. Ann Allergy (1990) 0.75
Re: Detection of prostate specific antigen in pancreas and salivary glands: a potential impact on prostate cancer overestimation. J Urol (1998) 0.75
Detection of human immunodeficiency virus in blood or semen by polymerase chain reaction--reliable. Fertil Steril (1993) 0.75
Antibodies in malignant disease. Br Med J (1972) 0.75
Prostaglandin E2 affects the tumor immune response in prostatic carcinoma. J Urol (1982) 0.75
Soluble Fc gamma receptors and the maternal-fetal response. J Leukoc Biol (1994) 0.75
What of the clinical significance of the cryoimmune response? Dermatol Surg (1997) 0.75
Cryoimmunotherapy: continuing studies toward determining a rational approach for assessing the candidacy of the prostatic cancer patient for cryoimmunotherapy and postoperative responsiveness. An interim report. Cryobiology (1980) 0.75
Immunologic dysfunction in patients with hemophilia. Can Med Assoc J (1984) 0.75
Justice versus equity for haemophiliacs with AIDS. BMJ (1990) 0.75
Pemphigus-like antigens and antibodies in benign and malignant neoplasms. Arch Dermatol Res (1983) 0.75